NCDActive
Transillumination Light Scanning or Diaphanography
NCD258
Effective: January 1, 1966
Updated: December 31, 2025
Policy Summary
Transillumination light scanning (diaphanography) for detection of breast cancer or other breast diseases is considered investigational and is not covered; program payment may not be made for this procedure at this time. The technology's usefulness relative to existing breast cancer detection methods has not been established, and further study is needed.
Coverage Criteria Preview
Key requirements from the full policy
"Transillumination light scanning (diaphanography) of the breast is not covered; program payment may not be made for this procedure at this time."
Sign up to see full coverage criteria, indications, and limitations.